Advertisement
Journal Home
Search for

Volume 51, Issue 2, Pages 105-128 (March 2006)


View previous. 2 of 11 View next.

Skew Deviation Revisited

Michael C. Brodsky, MD1Corresponding Author Informationemail address, Sean P. Donahue, MD, PhD2, Michael Vaphiades, DO3, Thomas Brandt, MD4

Abstract 

Skew deviation is a vertical misalignment of the eyes caused by damage to prenuclear vestibular input to ocular motor nuclei. The resultant vertical ocular deviation is relatively comitant in nature, and is usually seen in the context of brainstem or cerebellar injury from stroke, multiple sclerosis, or trauma. Skew deviation is usually accompanied by binocular torsion, torticollis, and a tilt in the subjective visual vertical. This constellation of findings has been termed the ocular tilt reaction. In the past two decades, a clinical localizing value for skew deviation has been assigned, and a cogent vestibular mechanism for comitant and incomitant variants of skew deviation has been proposed. Our understanding of skew deviation as a manifestation of central otolithic dysfunction in different planes of three-dimensional space is evolving. The similar spectrum of vertical ocular deviations arising in patients with congenital strabismus may further expand the nosology of skew deviation to include vergence abnormalities caused by the effects of early binocular visual imbalance on the developing visual system.

1 Departments of Ophthalmology and Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

2 Department of Ophthalmology and Visual Sciences, Pediatrics, and Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

3 Department of Ophthalmology, University of Alabama, Birmingham, Alabama, USA

4 Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians University, Münich, Germany

Corresponding Author InformationReprint address: Michael C. Brodsky, M.D., Arkansas Children's Hospital, 800 Marshall, Little Rock, Arkansas 72202.

 Supported in part by a grant from The Pat and Willard Walker Foundation, Jones Eye Institute, and Research to Prevent Blindness, Inc. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(05)00214-6

doi:10.1016/j.survophthal.2005.12.008


View previous. 2 of 11 View next.

Advertisement